Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lowered by Gilder Gagnon Howe & Co. LLC

Gilder Gagnon Howe & Co. LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 473,846 shares of the medical equipment provider’s stock after selling 2,814 shares during the quarter. Intuitive Surgical accounts for about 2.7% of Gilder Gagnon Howe & Co. LLC’s holdings, making the stock its 6th biggest holding. Gilder Gagnon Howe & Co. LLC owned approximately 0.13% of Intuitive Surgical worth $247,329,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Howard Capital Management Group LLC boosted its stake in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. raised its holdings in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares during the last quarter. World Investment Advisors LLC purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $228,000. Arvest Bank Trust Division bought a new stake in Intuitive Surgical in the 3rd quarter worth $260,000. Finally, Wilmington Savings Fund Society FSB increased its position in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ISRG shares. Truist Financial cut their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada dropped their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $598.95.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $514.59 on Friday. The company has a market capitalization of $183.29 billion, a price-to-earnings ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $367.39 and a one year high of $616.00. The company’s 50-day moving average is $511.92 and its 200 day moving average is $532.42.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the company posted $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,454 shares of company stock worth $18,564,027. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.